title: Inhibition of the metabolic degradation of filtered albumin is a major determinant of albuminuria.
abstract: Inhibition of the degradation of filtered albumin has been proposed as a widespread, benign form of albuminuria. There have however been recent reports that radiolabeled albumin fragments in urine are not exclusively generated by the kidney and that in albuminuric states albumin fragment excretion is not inhibited. In order to resolve this controversy we have examined the fate of various radiolabeled low molecular weight protein degradation products (LMWDPs) introduced into the circulation in rats. The influence of puromycin aminonucleoside nephrosis on the processing and excretion of LMWDPs is also examined. The status and destinies of radiolabeled LMWDPs in the circulation are complex. A major finding is that LMWDPs are rapidly eliminated from the circulation (>97% in 2 h) but only small quantities (<4%) are excreted in urine. Small (<4%) but significant amounts of LMWDPs may have prolonged elimination (>24 h) due to binding to high molecular weight components in the circulation. If LMWDPs of albumin seen in the urine are produced by extra renal degradation it would require the degradation to far exceed the known catabolic rate of albumin. Alternatively, if an estimate of the role of extra renal degradation is made from the limit of detection of LMWDPs in plasma, then extra renal degradation would only contribute <1% of the total excretion of LMWDPs of albumin. We confirm that the degradation process for albumin is specifically associated with filtered albumin and this is inhibited in albuminuric states. This inhibition is also the primary determinant of the massive change in intact albuminuria in nephrotic states.
authors.affiliation: Department of Biochemistry and Molecular Biology, Monash University, Clayton, Victoria 3800, Australia.
authors.forename: Julijana
authors.initials: J
authors.lastname: Vuchkova
authors.affiliation: SalAqua Diagnostics Inc., Suite 258, 888c 8th Ave, New York, New York, 10019, United States of America.
authors.forename: Wayne D
authors.initials: WD
authors.lastname: Comper
mesh_terms: D000418:Albumins / Q000378:metabolism*; D000419:Albuminuria / Q000378:metabolism* / Q000652:urine; D000818:Animals; D002850:Chromatography, Gel; D016014:Linear Models; D008660:Metabolism; D008970:Molecular Weight; D009401:Nephrosis / Q000139:chemically induced; D062106:Protein Degradation End Products / Q000097:blood* / Q000652:urine; D011692:Puromycin Aminonucleoside / Q000009:adverse effects*; D011877:Radionuclide Imaging; D051381:Rats; D014316:Tritium
chemical_list: D000418:Albumins; D062106:Protein Degradation End Products; D014316:Tritium; D011692:Puromycin Aminonucleoside